Journal of Viral Hepatitis

Antiviral resistance and specifically targeted therapy for HCV (STAT-C)
pp. 377-387(11)
Authors: Thompson, A. J. V.; McHutchison, J. G.

Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients
pp. 388-396(9)
Authors: Wada, M.; Marusawa, H.; Yamada, R.; Nasu, A.; Osaki, Y.; Kudo, M.; Nabeshima, M.; Fukuda, Y.; Chiba, T.; Matsuda, F.

Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection
pp. 397-405(9)
Authors: Tarantino, G.; Marco, V. D.; Petta, S.; Almasio, P. L.; Barbaria, F.; Licata, A.; Bosco, G. L.; Tripodo, C.; Stefano, R. D.; Craxì, A.

Entire genome sequences of two new HCV subtypes, 6r and 6s, and characterization of unique HVR1 variation patterns within genotype 6
pp. 406-417(12)
Authors: Li, C.; Lu, L.; Zhang, X.; Murphy, D.

The HCV serum proteome: a search for fibrosis protein markers
pp. 418-429(12)
Authors: Cheung, K. J.; Tilleman, K.; Deforce, D.; Colle, I.; Van Vlierberghe, H.

Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study
pp. 430-436(7)
Authors: Mavrogiannaki, A.; Karamanos, B.; Manesis, E. K.; Papatheodoridis, G. V.; Koskinas, J.; Archimandritis, A. J.

Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study
pp. 437-443(7)
Authors: Ikeda, K.; Kobayashi, M.; Someya, T.; Saitoh, S.; Hosaka, T.; Akuta, N.; Suzuki, F.; Suzuki, Y.; Arase, Y.; Kumada, H.

Complete blood count reflects the degree of oesophageal varices and liver fibrosis in virus-related chronic liver disease patients
pp. 444-452(9)
Authors: Lee, J.-H.; Yoon, J.-H.; Lee, C.-H.; Myung, S. J.; Keam, B.; Kim, B. H.; Chung, G. E.; Kim, W.; Kim, Y. J.; Jang, J. J.; Lee, H-S.